CDC Shortens Isolation Window for Positive COVID-19 Result to Five Days

The Centers for Disease Control and Prevention has updated the amount of time it recommends people isolate themselves after testing positive for COVID-19, shortening it from 10 days to five.

“Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others,” the CDC said in a statement Monday.

The CDC changed the guidance because officials believe the data indicates the majority of COVID-19 transmission takes place early in the course of the illness, “generally in the 1-2 days prior to onset of symptoms and the 2-3 days after,” the statement said.

Read More

70 Percent of Adult Virginians Have Received at Least One Dose of COVID-19 Vaccine

Governor Ralph Northam announced Monday that Virginia has reached a key vaccination milestone: 70 percent of adult Virginians have received at least one dose of a COVID-19 vaccine.

“Virginia has reached a significant milestone in the fight against COVID-19,” Northam said in his announcement. “Thanks to the millions of Virginians who have rolled up their sleeves to get vaccinated, the virus is in retreat, our economy is growing, and we are closer to putting this pandemic behind us.”

Read More

Rare Heart Inflammation Following COVID-19 Vaccination Sparks Emergency CDC Meeting

Doctors working on patient

The Centers for Disease Control and Prevention will discuss reports of a rare heart inflammation following doses of mRNA-based COVID-19 vaccines in an emergency meeting, it announced Thursday.

The emergency meeting, set to take place on June 18, will include updates on mRNA COVID-19 vaccine safety with a specific focus on rare reports of myocarditis and pericarditis, Scott Pauley of the CDC told The Daily Caller News Foundation. The risks and benefits of administering the mRNA COVID-19 vaccines to adolescents and young adults will also be discussed, according to the meeting’s agenda.

The announcement comes following a presentation to the Food and Drug Administration by Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, confirming 226 cases of myocarditis/pericarditis in people under 30. These cases are more than twice what was expected under the FDA’s safety assessment for COVID-19 vaccines.

Read More